-transparent.png){kind=logo}
Gastrin and pancreastatin-like immunoreactivity were determined by radioimmunoassay methods and chromogranin A was determined by enzyme-linked immunoassay in sera from 18 patients with gastrinomas (Zollinger-Ellison syndrome) and in 20 age and sex matched controls. Gastrin serum levels in the gastrinoma patients were in the range 26-80,000 pmol/l, and in the controls 5-31 pmol/l. Chromogranin A serum levels in the gastrinoma group were in the range 6-2,700 ng/ml (mean +/- SEM: 400 +/- 147 ng/ml). The mean value of chromogranin A was significantly higher than in the control group (8 +/- 2 ng/ml, p = 0.008). The serum levels of pancreastatin-like immunoreactivity in the gastrinoma patients were in the range 23-1,994 pg/ml (597 +/- 123 pg/ml). The mean value of pancreastatin-like immunoreactivity in the gastrinoma group was significantly higher than in the control group (104 +/- 25 pg/ml, p = 0.0002). The levels of chromogranin A and pancreastatin-like immunoreactivity were significantly higher in patients with verified metastatic disease (p = 0.04, p = 0.01 respectively). There was a significantly positive correlation between levels of gastrin and pancreastatin-like immunoreactivity (r = 0.7, p = 0.002), while no correlation was found between gastrin and chromogranin A levels or between levels of chromogranin A and pancreastatin-like immunoreactivity. The study demonstrates an elevation of both chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. The lack of correlation between gastrin and chromogranin A, however, gives an indication that the gastrinoma cells are not the main source of serum chromogranin A elevation.
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
December 1996,
The Journal of clinical endocrinology and metabolism,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
March 1994,
Neuropeptides,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
October 1990,
The Journal of clinical endocrinology and metabolism,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
April 1992,
Cell and tissue research,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
January 1987,
Nature,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
March 1991,
Regulatory peptides,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
December 1989,
The Journal of clinical endocrinology and metabolism,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
January 2017,
Histology and histopathology,
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
April 1990,
Archives of surgery (Chicago, Ill. : 1960),
U Syversen, and
M Mignon, and
S Bonfils, and
A Kristensen, and
H L Waldum
April 1994,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
